I see that a few of the other side are posting now. First, I want Dr Recknor to be excellent at the task that he is in charge of. That’s not being the primary spokesman. Although even my humble ears understand a lot better his lab and it’s aims, I hope for more elaboration by our medical elite. I did hear strong reassurance about Brazil, not only on the Covid trials but the AE global reach and reputation. I also hear that Brazil is interested in longhaulers. And that for the long run they are a lower cost option and can respond to incentives. I hear that India is interested in longhaulers. I hear a reaffirmation that the deadline for BLA had not changed. We are awaiting reaction from FDA. Cydy May publish original FDA comments about receptor occupancy tests. The only thing more confusing to me was NASH. But that may be the audio. All in all, a strong, professional conference call with more details, more progress. Nothing earthshaking, but I feel we have a team and a plan! Imho